Jade Biosciences, Inc.
JBIO
$12.00
$0.383.27%
NASDAQ
| 09/30/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 184.34% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 76.16% | ||||
| Operating Income | -76.16% | ||||
| Income Before Tax | -49.26% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -49.26% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -49.26% | ||||
| EBIT | -76.16% | ||||
| EBITDA | -- | ||||
| EPS Basic | 90.98% | ||||
| Normalized Basic EPS | 86.77% | ||||
| EPS Diluted | 90.98% | ||||
| Normalized Diluted EPS | 86.77% | ||||
| Average Basic Shares Outstanding | 1,154.46% | ||||
| Average Diluted Shares Outstanding | 1,154.46% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||